Header Logo

Connection

JIANQIANG MAO to Non-alcoholic Fatty Liver Disease

Back to Details
This is a "connection" page, showing publications JIANQIANG MAO has written about Non-alcoholic Fatty Liver Disease.
JIANQIANG MAO
Connection Strength
0.098
Non-alcoholic Fatty Liver Disease
  1. Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD. Sci Rep. 2017 09 18; 7(1):11793.
    View in: PubMed
    Score: 0.098
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.